# Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia

> **NCT02348788** · PHASE3 · UNKNOWN · sponsor: **Menzies School of Health Research** · enrollment: 98 (estimated)

## Conditions studied

- Plasmodium Vivax Malaria Without Complication

## Interventions

- **DRUG:** Artemether-lumefantrine + Primaquine
- **DRUG:** Chloroquine + Primaquine

## Key facts

- **NCT ID:** NCT02348788
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348788, "Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02348788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*